ISSN2456-3315
Impact Factor10.57
UGC CAREApproved
Low Cost₹599 / $45
CrossRefDOI
ESTD2016
Peer ReviewTransparent
AccessOpen
Submission: Always Open
Paper Title
Survey on The Sales of Four-Molecule Antihypertensive Medications in The Private Healthcare Sector in Amravati
Authors
Om Raut , Rutushna Surwade , Ashish Wadekar , Sakshi Mankar
Keywords
Heart Disease, Risk Factors, Telmisartan, Survey, Antihypertensive Medication, High Sales, Maharashtra India, Amravati District.
Abstract
Hypertension is a significant global health concern, causing 10.8% of fatalities in India and 25% in Maharashtra. It accounts for 51% of stroke deaths and 45% of heart disease deaths. Early identification and treatment of hypertension and other risk factors have reduced cardiovascular disease deaths. Managing hypertension and reducing risk factors like diabetes, dyslipidemia, and smoking are crucial. Lowering blood pressure by 5 mmHg can reduce stroke risk by 34%. A study in Amravati, India, found that doctors prescribe antihypertensive medications like telmisartan for high blood pressure. Some drugs are cost-effective and economically beneficial, while others are less popular due to cost and physician preference. The study aimed to identify market share and address medication concerns. A study in Amravati, India, involving 100 pharmacists, 50 patients, and 10 physicians, found that doctors prescribe telmisartan for high blood pressure. Factors like efficacy, side effects, and comorbidities influenced patient decisions. High sales of certain drug categories, such as Telmikind-40, Concor-5, Beta-cap, Telista Trio CL 6.25, and Furosemide Inj. IP, can inform further pharma marketing and policy changes.
Full Paper, Downloads & Preview
How To Cite
Choose the style your journal or department asks for, then copy it. Every version below is generated from this paper's own record.
IJRTI — journal style
"Survey on The Sales of Four-Molecule Antihypertensive Medications in The Private Healthcare Sector in Amravati", IJRTI - International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2456-3315, Vol.9, Issue 5, page no.485 - 497, May-2024, Available :https://ijrti.org/papers/IJRTI2405073.pdf
APA — 7th edition
Raut, O., Surwade, R., Wadekar, A., & Mankar, S. (2024). Survey on The Sales of Four-Molecule Antihypertensive Medications in The Private Healthcare Sector in Amravati. International Journal for Research Trends and Innovation, 9(5), 485 - 497. https://ijrti.org/viewpaperforall.php?paper=IJRTI2405073
MLA — 9th edition
Raut, Om, et al. "Survey on The Sales of Four-Molecule Antihypertensive Medications in The Private Healthcare Sector in Amravati." International Journal for Research Trends and Innovation, vol. 9, no. 5, 2024, pp. 485 - 497, https://ijrti.org/viewpaperforall.php?paper=IJRTI2405073.
Chicago — 17th, bibliography
Raut, Om, et al. "Survey on The Sales of Four-Molecule Antihypertensive Medications in The Private Healthcare Sector in Amravati." International Journal for Research Trends and Innovation 9, no. 5 (2024): 485 - 497. https://ijrti.org/viewpaperforall.php?paper=IJRTI2405073.
Harvard — author–date
Raut, O. et al. (2024) 'Survey on The Sales of Four-Molecule Antihypertensive Medications in The Private Healthcare Sector in Amravati', International Journal for Research Trends and Innovation, 9(5), pp. 485 - 497. Available at: https://ijrti.org/viewpaperforall.php?paper=IJRTI2405073
IEEE — numbered reference
O. Raut, R. Surwade, A. Wadekar and S. Mankar, "Survey on The Sales of Four-Molecule Antihypertensive Medications in The Private Healthcare Sector in Amravati," IJRTI, vol. 9, no. 5, pp. 485 - 497, May. 2024.
Vancouver — biomedical
Raut O, Surwade R, Wadekar A, Mankar S. Survey on The Sales of Four-Molecule Antihypertensive Medications in The Private Healthcare Sector in Amravati. IJRTI. 2024 May;9(5):485 - 497.
AMA — 11th edition
Raut O, Surwade R, Wadekar A, Mankar S. Survey on The Sales of Four-Molecule Antihypertensive Medications in The Private Healthcare Sector in Amravati. IJRTI. 2024;9(5):485 - 497. Accessed at https://ijrti.org/viewpaperforall.php?paper=IJRTI2405073
BibTeX — Zotero, Mendeley, LaTeX
@article{IJRTI2405073,
author = {Om Raut and Rutushna Surwade and Ashish Wadekar and Sakshi Mankar},
title = {Survey on The Sales of Four-Molecule Antihypertensive Medications in The Private Healthcare Sector in Amravati},
journal = {International Journal for Research Trends and Innovation},
volume = {9},
number = {5},
pages = {485 - 497},
year = {2024},
month = {May},
issn = {2456-3315},
url = {https://ijrti.org/viewpaperforall.php?paper=IJRTI2405073}
}
RIS — EndNote, RefWorks
TY - JOUR
AU - Raut, Om
AU - Surwade, Rutushna
AU - Wadekar, Ashish
AU - Mankar, Sakshi
TI - Survey on The Sales of Four-Molecule Antihypertensive Medications in The Private Healthcare Sector in Amravati
T2 - International Journal for Research Trends and Innovation
JA - IJRTI
VL - 9
IS - 5
PY - 2024
SN - 2456-3315
UR - https://ijrti.org/viewpaperforall.php?paper=IJRTI2405073
SP - 485
EP - 497
ER -
Issue
Volume 9 Issue 5,
May-2024
Pages : 485 - 497
Other Publication Details
Paper Reg. ID
IJRTI_189915
Published Paper ID
IJRTI2405073
Downloads
205,641
Research Area
Pharmacy
Country
Amravati, Maharashtra, India
Published
May 2024
Published Paper PDF
https://ijrti.org/papers/IJRTI2405073.pdf
Published Paper URL
https://ijrti.org/viewpaperforall.php?paper=IJRTI2405073
About Publisher
International Journal for Research Trends and Innovation
Published by IJRTI (JW Publication)
2456-3315
ISSN
10.57
Impact Factor
2016
ESTD Year
Open
Access
Impact Factor 10.57 calculated by Google Scholar and Semantic Scholar.
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 10.57 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
UGC CARE Approved Journal — Transparent Peer-reviewed journal aligned with UGC’s 2025 suggestive parameters, with CrossRef DOI registration and Scopus Standard metadata on every published paper.
Licence
© 2024 — Authors hold the copyright of this article.
This work is licensed under a
Creative Commons Attribution 4.0 International License
and The Open Definition.
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0),
which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Disclaimer:
The content, data and findings in this article are based on the authors’ research and have been
peer-reviewed for academic purposes only. Readers are advised to verify all information before practical
or commercial use. The journal and its editorial board are not liable for any errors, losses or
consequences arising from its use.
Declarations
Funding
No external funding was received for this study.
Conflict of Interest
The authors declare that they have no conflict of interest.
Acknowledgements
The authors would like to thank the reviewers and the editorial board of International Journal for Research Trends and Innovation for their careful reading and constructive comments, and all colleagues who supported the preparation of this manuscript.
